Haw Par Corporation Limited (HAWPY)
USD 28.64
(0.0%)
USD 28.64
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 19 Million SGD | -1.26% |
| 2022 | 19.24 Million SGD | 46.09% |
| 2021 | 13.17 Million SGD | -14.02% |
| 2020 | 15.32 Million SGD | -23.9% |
| 2019 | 20.13 Million SGD | -17.74% |
| 2018 | 24.47 Million SGD | 42.93% |
| 2017 | 17.12 Million SGD | 48.62% |
| 2016 | 11.52 Million SGD | -6.88% |
| 2015 | 12.37 Million SGD | 15.44% |
| 2014 | 10.72 Million SGD | 10.39% |
| 2013 | 9.71 Million SGD | -3.85% |
| 2012 | 10.1 Million SGD | 20.54% |
| 2011 | 8.37 Million SGD | -9.66% |
| 2010 | 9.27 Million SGD | 52.3% |
| 2009 | 6.09 Million SGD | -7.14% |
| 2008 | 6.55 Million SGD | 17.19% |
| 2007 | 5.59 Million SGD | -8.92% |
| 2006 | 6.14 Million SGD | -36.69% |
| 2005 | 9.7 Million SGD | 19.62% |
| 2004 | 8.11 Million SGD | 18.85% |
| 2003 | 6.82 Million SGD | -6.3% |
| 2002 | 7.28 Million SGD | -34.34% |
| 2001 | 11.09 Million SGD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 21.44 Million SGD | 12.85% |
| 2024 Q2 | 21.44 Million SGD | 0.0% |
| 2023 Q3 | 19 Million SGD | -0.63% |
| 2023 Q1 | 19.12 Million SGD | -0.63% |
| 2023 FY | 19 Million SGD | -1.26% |
| 2023 Q4 | 19 Million SGD | 0.0% |
| 2023 Q2 | 19.12 Million SGD | 0.0% |
| 2022 Q3 | 19.24 Million SGD | 21.07% |
| 2022 Q4 | 19.24 Million SGD | 0.0% |
| 2022 Q1 | 15.89 Million SGD | 20.67% |
| 2022 FY | 19.24 Million SGD | 46.09% |
| 2022 Q2 | 15.89 Million SGD | 0.0% |
| 2021 Q1 | 13.63 Million SGD | -11.03% |
| 2021 Q2 | 13.63 Million SGD | 0.0% |
| 2021 FY | 13.17 Million SGD | -14.02% |
| 2021 Q3 | 13.17 Million SGD | -3.36% |
| 2021 Q4 | 13.17 Million SGD | 0.0% |
| 2020 Q4 | 15.32 Million SGD | 0.0% |
| 2020 Q3 | 15.32 Million SGD | -13.39% |
| 2020 Q2 | 17.69 Million SGD | 0.0% |
| 2020 Q1 | 17.69 Million SGD | -12.14% |
| 2020 FY | 15.32 Million SGD | -23.9% |
| 2019 Q4 | 20.13 Million SGD | 3.84% |
| 2019 FY | 20.13 Million SGD | -17.74% |
| 2019 Q3 | 19.39 Million SGD | -10.8% |
| 2019 Q1 | 23.85 Million SGD | -2.54% |
| 2019 Q2 | 21.74 Million SGD | -8.87% |
| 2018 Q1 | 17.18 Million SGD | 0.35% |
| 2018 Q4 | 24.47 Million SGD | 27.5% |
| 2018 Q3 | 19.19 Million SGD | 22.19% |
| 2018 Q2 | 15.71 Million SGD | -8.57% |
| 2018 FY | 24.47 Million SGD | 42.93% |
| 2017 Q4 | 17.12 Million SGD | 6.09% |
| 2017 Q3 | 16.14 Million SGD | 33.56% |
| 2017 Q2 | 12.08 Million SGD | 17.22% |
| 2017 Q1 | 10.31 Million SGD | -10.52% |
| 2017 FY | 17.12 Million SGD | 48.62% |
| 2016 FY | 11.52 Million SGD | -6.88% |
| 2016 Q2 | 10.64 Million SGD | -0.83% |
| 2016 Q4 | 11.52 Million SGD | 1.6% |
| 2016 Q1 | 10.72 Million SGD | -13.3% |
| 2016 Q3 | 11.34 Million SGD | 6.6% |
| 2015 Q1 | 9.44 Million SGD | -11.91% |
| 2015 Q3 | 9.89 Million SGD | 0.34% |
| 2015 Q4 | 12.37 Million SGD | 25.03% |
| 2015 FY | 12.37 Million SGD | 15.44% |
| 2015 Q2 | 9.86 Million SGD | 4.46% |
| 2014 Q2 | 9.93 Million SGD | 4.31% |
| 2014 Q1 | 9.52 Million SGD | -1.88% |
| 2014 FY | 10.72 Million SGD | 10.39% |
| 2014 Q4 | 10.72 Million SGD | 11.66% |
| 2014 Q3 | 9.6 Million SGD | -3.4% |
| 2013 Q2 | 10.07 Million SGD | -12.14% |
| 2013 Q1 | 11.46 Million SGD | 13.55% |
| 2013 FY | 9.71 Million SGD | -3.85% |
| 2013 Q4 | 9.71 Million SGD | 7.47% |
| 2013 Q3 | 9.03 Million SGD | -10.33% |
| 2012 FY | 10.1 Million SGD | 20.54% |
| 2012 Q4 | 10.1 Million SGD | 12.65% |
| 2012 Q3 | 8.96 Million SGD | -3.07% |
| 2012 Q1 | 9.28 Million SGD | 10.79% |
| 2012 Q2 | 9.25 Million SGD | -0.36% |
| 2011 FY | 8.37 Million SGD | -9.66% |
| 2011 Q4 | 8.37 Million SGD | 11.91% |
| 2011 Q2 | 8.17 Million SGD | -0.85% |
| 2011 Q3 | 7.48 Million SGD | -8.46% |
| 2011 Q1 | 8.24 Million SGD | -11.06% |
| 2010 FY | 9.27 Million SGD | 52.3% |
| 2010 Q1 | 6.23 Million SGD | 2.32% |
| 2010 Q2 | 7.24 Million SGD | 16.29% |
| 2010 Q3 | 7.48 Million SGD | 3.27% |
| 2010 Q4 | 9.27 Million SGD | 23.95% |
| 2009 Q4 | 6.09 Million SGD | 0.0% |
| 2009 FY | 6.09 Million SGD | -7.14% |
| 2008 FY | 6.55 Million SGD | 17.19% |
| 2007 FY | 5.59 Million SGD | -8.92% |
| 2006 FY | 6.14 Million SGD | -36.69% |
| 2005 FY | 9.7 Million SGD | 19.62% |
| 2004 FY | 8.11 Million SGD | 18.85% |
| 2003 FY | 6.82 Million SGD | -6.3% |
| 2002 Q4 | 7.28 Million SGD | 0.0% |
| 2002 Q2 | 7.33 Million SGD | 0.0% |
| 2002 FY | 7.28 Million SGD | -34.34% |
| 2001 FY | 11.09 Million SGD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AstraZeneca PLC | 5.41 Billion USD | 99.649% |
| Bristol-Myers Squibb Company PFD CONV 2 | 2.66 Billion USD | 99.286% |
| CSPC Pharmaceutical Group Limited | 442.43 Million USD | 95.704% |
| Clarus Therapeutics Holdings, Inc. | 14.21 Million USD | -33.706% |
| Novartis AG | 5.91 Billion USD | 99.679% |
| PT Kalbe Farma Tbk. | 451.27 Million USD | 95.789% |